Parasite and Vector Research Unit (PAVRU), Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon; Research Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Institute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), Bonn, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany; German-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site Bonn, Bonn, Germany.
Exp Parasitol. 2024 Oct;265:108822. doi: 10.1016/j.exppara.2024.108822. Epub 2024 Aug 9.
Mansonella perstans infections are widespread in Sub-Saharan Africa and Central and South America and thus can be considered as the most prevalent parasite of man in tropical Africa. In contrast to the high prevalence, knowledge about the biology of this filarial nematode is restricted and no effective treatment regimens of this ivermectin-resistant parasite is lacking. An obstacle for the research is that M. perstans resides in body cavities and thus have been only rarely recovered during surgery or autopsy. Therefore, alternative methods like in vitro culture systems need to be implemented to decipher the nature of mansonellosis and effective drugs. Previously, we have established a monkey kidney epithelial cell-based in vitro culture for the maintenance of M. perstans infective larvae (L3) up to 77 days. However, no alternative for this culture system have been postulated to allow longer survival rates and development of adult worms in vitro. Thus, we aim to establish an alternative in vitro culture system for M. perstans L3. M. perstans L3 were isolated from engorged and laboratory reared Culicoides midges. The larvae were then cultured in Dulbecco's Modified Eagle Medium supplemented with either 10% foetal bovine serum (FBS), 10% newborn calf serum (NCS) or 1% bovine serum albumin (BSA) together with human colon carcinoma cells (HCT-8) as feeder cells. Survival and growth were recorded. We obtained that the 10% NCS culture condition was superior allowing long-term maintenance of M. perstans L3 for up to 100 days and boosted growth of the parasites for up to 5-folds compared to the initial size at culture inception. Although no moulting of the L3 into L4 or adult worms could be overserved, the human colon carcinoma cell-based in vitro culture provides an alternative platform to analyse M. perstans biology and screen for novel drugs against M. perstans.
曼森线虫感染在撒哈拉以南非洲、中美洲和南美洲广泛传播,因此可以被认为是热带非洲最普遍的人体寄生虫。与高流行率形成对比的是,人们对这种丝虫的生物学知识了解有限,而且缺乏针对这种伊维菌素耐药寄生虫的有效治疗方案。研究的一个障碍是曼森线虫栖息在体腔中,因此在手术或尸检中很少被发现。因此,需要建立体外培养系统等替代方法来解析曼森线虫病的本质和有效的药物。以前,我们已经建立了一种基于猴肾上皮细胞的体外培养系统,可将曼森线虫感染性幼虫(L3)维持长达 77 天。然而,还没有提出替代该培养系统的方法来允许更长的存活率和在体外发育成虫。因此,我们旨在建立一种替代的曼森线虫 L3 体外培养系统。从饱血和实验室饲养的库蠓中分离出曼森线虫 L3。然后将幼虫在补充有 10%胎牛血清(FBS)、10%新生牛血清(NCS)或 1%牛血清白蛋白(BSA)的杜尔贝科改良伊格尔培养基中培养,同时用人结肠癌细胞(HCT-8)作为饲养细胞。记录存活率和生长情况。我们发现,10%NCS 培养条件更优越,可将曼森线虫 L3 维持长达 100 天,与培养开始时的初始大小相比,寄生虫的生长速度提高了 5 倍。虽然没有观察到 L3 蜕皮成 L4 或成虫,但基于人结肠癌细胞的体外培养为分析曼森线虫生物学和筛选针对曼森线虫的新型药物提供了替代平台。